Sonoma Pharmaceuticals, Inc. (SNOA) Ownership
SNOA ownership summary
as of October 18, 2026- Institutions
- 2.3% of shares outstanding
- Insiders
- 0.42% of shares outstanding
- Shares outstanding
- 4.8M
- Float
- 4.8M shares available to trade
- Short interest
- 3.45% 165K shares short
- Days to cover
- 3.13 short interest down 18.4% vs prior month
- Institutions 2.31%
- Insiders 0.42%
- Other investors 97.27%
SNOA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies Corp | 0.85% | 40K | $45,324 | +40,468 (0.0%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.56% | 27K | $30,001 | +6,846 (+34.3%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.39% | 19K | $21,041 | — | June 30, 2026 |
| 4 | Mckinley Carter Wealth Services Inc | 0.23% | 11K | $12,536 | — | June 30, 2026 |
| 5 | UBS Group AG | 0.16% | 7,808 | $8,745 | +7,802 (+130,033.3%) | June 30, 2026 |
| 6 | Global Retirement Partners, LLC. | 0.05% | 2,548 | $2,854 | +1,776 (+230.1%) | June 30, 2026 |
| 7 | Morgan Stanley - Brokerage Accounts | 0.04% | 2,000 | $2,240 | −4 (−0.2%) | June 30, 2026 |
| 8 | Advisor Group Holdings, Inc. | 0.01% | 500 | $560 | — | June 30, 2026 |
| 9 | Barclays PLC | 0.01% | 459 | $514 | +459 (0.0%) | June 30, 2026 |
| 10 | BlackRock Inc | <0.01% | 113 | $127 | — | June 30, 2026 |
| 11 | Vanguard Fiduciary Trust Co | <0.01% | 100 | $112 | — | June 30, 2026 |
| 12 | HARBOUR INVESTMENTS, INC. | <0.01% | 15 | $17 | +15 (0.0%) | June 30, 2026 |
| 13 | Quaker Wealth Management, LLC | <0.01% | 3 | $3 | — | June 30, 2026 |
| 14 | Danske Bank A/S. | 0.00% | 1 | $1 | — | June 30, 2026 |
| 15 | CWM, LLC duplicate | 0.00% | 1 | $1 | +1 (0.0%) | March 31, 2026 |
| 16 | DRW Securities, LLC | 0.00% | — | — | −12,015 (−100.0%) | June 30, 2026 |
| 17 | Tower Research Capital LLC | 0.00% | — | — | −1,231 (−100.0%) | June 30, 2026 |
| 18 | Caitong International Asset Management Co., Limited. | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 19 | Citigroup Inc | 0.00% | — | — | −1,425 (−100.0%) | June 30, 2026 |
| 20 | U.S. Bancorp | 0.00% | — | — | −25 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 57K shares and 6 cut 15K.
SNOA top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.43% | 21K | $23,293 | −112 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Total Market Index | 0.05% | 2,528 | $2,831 | — | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.05% | 2,314 | $2,592 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
SNOA insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2018-03-12 | Robert E Miller | Buy | $3.97 | 2,400 | $9,528 |
| 2018-03-09 | Robert E Miller | Buy | $3.90 | 1,200 | $4,680 |
| 2018-03-08 | James J Schutz | Buy | $3.99 | 2,473 | $9,867 |
| 2017-11-29 | James J Schutz | Buy | $5.03 | 400 | $2,012 |
| 2017-11-29 | Robert E Miller | Buy | $5.02 | 1,790 | $8,986 |
| 2017-11-24 | James J Schutz | Buy | $5.05 | 254 | $1,283 |
| 2017-11-21 | Robert E Miller | Buy | $5.03 | 2,000 | $10,060 |
| 2017-08-10 | James J Schutz | Buy | $5.46 | 929 | $5,072 |
| 2017-08-10 | Marc Umscheid | Buy | $5.31 | 600 | $3,186 |
| 2017-08-10 | Robert E Miller | Buy | $5.30 | 2,264 | $11,999 |
| 2017-03-09 | Robert E Miller | Buy | $7.02 | 750 | $5,265 |
| 2017-03-08 | Robert E Miller | Buy | $6.93 | 1,000 | $6,930 |
| 2017-03-06 | Marc Umscheid | Buy | $6.82 | 750 | $5,115 |
| 2017-03-03 | James J Schutz | Buy | $6.78 | 800 | $5,424 |
| 2016-12-08 | James J Schutz | Buy | $4.88 | 1,000 | $4,880 |
| 2016-12-08 | Robert E Miller | Buy | $4.86 | 5,000 | $24,300 |
| 2016-08-15 | James J Schutz | Buy | $3.66 | 1,328 | $4,860 |
| 2016-02-25 | James J Schutz | Buy | $1.00 | 5,000 | $5,000 |
| 2014-11-17 | James J Schutz | Buy | $1.78 | 6,285 | $11,187 |
| 2013-08-16 | James Schutz | Buy | $2.35 | 5,100 | $11,985 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
SNOA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SNOA
Institutional investors own 2.3% of Sonoma Pharmaceuticals's shares and insiders 0.42%. The largest holder is Renaissance Technologies Corp with 0.85% of the shares (40K), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 6 reduced their stake in the latest filings. Short interest is 3.45% of the float, or 3.13 days of average trading volume. The share count rose 4,384.3% since 2014.
Related: SNOA analyst forecast, SNOA key metrics. See the SNOA stock overview for the latest quote and news.
SNOA ownership FAQ
Who owns the most Sonoma Pharmaceuticals stock?
The largest shareholders of Sonoma Pharmaceuticals are Renaissance Technologies Corp (0.85%), Geode Capital Management, LLC (0.56%), Vanguard Capital Management, LLC (0.39%), Mckinley Carter Wealth Services Inc (0.23%), UBS Group AG (0.16%).
What percentage of Sonoma Pharmaceuticals is owned by institutions?
Institutions hold 2.3% of Sonoma Pharmaceuticals's shares outstanding; insiders hold 0.42%.
Which funds own Sonoma Pharmaceuticals?
The largest fund holders of Sonoma Pharmaceuticals are Fidelity Extended Market Index (0.43%), Fidelity Total Market Index (0.05%), Fidelity Series Total Market Index (0.05%).
What is Sonoma Pharmaceuticals's short interest?
165K shares of Sonoma Pharmaceuticals were sold short, 3.45% of the float; at the average daily volume it would take 3.13 days to cover.
Are insiders buying or selling Sonoma Pharmaceuticals?
Of the latest 20 reported insider transactions in Sonoma Pharmaceuticals (since August 16, 2013), 20 were purchases and 0 were sales.
How many shares of Sonoma Pharmaceuticals are outstanding?
Sonoma Pharmaceuticals has 4.8M shares outstanding, of which 4.8M are in the public float.